IPO YEAR:
2018
|
Sector:
Health Care
|
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
|
ADRTSO:
|
MarketCap:
30334954722.00
|
Beta:
1.23813288874083
|
52 Week High:
497.49
|
52 Week Low:
122.01
|
52 Week Change:
-0.24835029638742867
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
403020216
|
Dividend Rate:
0
|
Dividend Yield:
8.13%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
27 Oct 2022
|
Float:
0
|
return on Equity:
-99.00%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
$4.564B
|
ttmEPS:
28.31
|
Revenue:
$25.476B
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
60.20%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
0.07%
|
Return on Assets:
4.50%
|
Return on Capital:
|
Profit Margin:
6.80%
|
Price to Sales:
3.26
|
Price To Book:
-
|
Short Ratio:
2.17
|
PE Ratio:
4.439431833515817
|
Employees:
1300
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
